Literature DB >> 17553896

Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection.

Lucy Golden-Mason1, Nicole Castelblanco, Cliona O'Farrelly, Hugo R Rosen.   

Abstract

Innate CD56(pos) natural killer (NK) and natural T (NT) cells comprise important hepatic antiviral effector lymphocytes whose activity is fine-tuned through surface NK receptors (NKRs). Dysregulation of NKRs in patients with long-standing hepatitis C virus (HCV) infection has been shown, but little is known regarding NKRs in acute infection. Treatment-naïve patients with acute HCV (n = 22), including 10 with spontaneous recovery, were prospectively studied. CD56(pos) NT levels were reduced early in acute HCV infection and did not fluctuate over time. In resolving HCV infection, NT cells with a more activated phenotype (lower CD158A and higher natural cytotoxicity receptor expression) at baseline predated spontaneous recovery. Moreover, NKG2A expression on CD56(+) NT cells correlated directly with circulating HCV RNA levels. Deficient interleukin-13 (IL-13) production by NT cells and reduced IL-2-activated killing (LAK) at baseline were associated with the ultimate development of persistence. These results indicate a previously unappreciated role for NT cells in acute HCV infection and identify a potential target for pharmacologic manipulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553896      PMCID: PMC1951454          DOI: 10.1128/JVI.00834-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors.

Authors:  Maria Cristina Mingari; Gabriella Pietra; Lorenzo Moretta
Journal:  Curr Opin Immunol       Date:  2005-06       Impact factor: 7.486

2.  Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

Authors:  J Nattermann; G Feldmann; G Ahlenstiel; B Langhans; T Sauerbruch; U Spengler
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

3.  CD94/NKG2A expression is associated with proliferative potential of CD8 T cells during persistent polyoma virus infection.

Authors:  Anthony M Byers; Nicolas P Andrews; Aron E Lukacher
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

4.  Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.

Authors:  Monica Gumá; Cecilia Cabrera; Itziar Erkizia; Margarita Bofill; Bonaventura Clotet; Lidia Ruiz; Miguel López-Botet
Journal:  J Infect Dis       Date:  2006-05-24       Impact factor: 5.226

5.  Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design.

Authors:  Susan Smyk-Pearson; Ian A Tester; Dennis Lezotte; Anna W Sasaki; David M Lewinsohn; Hugo R Rosen
Journal:  J Infect Dis       Date:  2006-07-12       Impact factor: 5.226

Review 6.  Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity.

Authors:  Tetsuo Takehara; Norio Hayashi
Journal:  Clin Gastroenterol Hepatol       Date:  2005-10       Impact factor: 11.382

Review 7.  Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity.

Authors:  Tatsuya Kanto; Norio Hayashi
Journal:  Intern Med       Date:  2006-03-15       Impact factor: 1.271

Review 8.  Natural killer cells: primary target for hepatitis C virus immune evasion strategies?

Authors:  Lucy Golden-Mason; Hugo R Rosen
Journal:  Liver Transpl       Date:  2006-03       Impact factor: 5.799

9.  Interleukin-2-inducible natural immune (lymphokine-activated killer cell) responses as a functional correlate of progression to AIDS.

Authors:  B G Brenner; M Gornitsky; M A Wainberg
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

10.  Obligatory role for interleukin-13 in obstructive lesion development in airway allografts.

Authors:  Vibha N Lama; Hiroaki Harada; Linda N Badri; Andrew Flint; Cory M Hogaboam; Andrew McKenzie; Fernando J Martinez; Galen B Toews; Bethany B Moore; David J Pinsky
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

View more
  29 in total

1.  CD56+ T cells inhibit HIV-1 infection of macrophages.

Authors:  Wei Hou; Li Ye; Wen-Zhe Ho
Journal:  J Leukoc Biol       Date:  2012-05-16       Impact factor: 4.962

2.  Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.

Authors:  Lucy Golden-Mason; Andrea L Cox; Jessica A Randall; Linling Cheng; Hugo R Rosen
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

3.  Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity.

Authors:  Lucy Golden-Mason; Amy E L Stone; Kiran M Bambha; Linling Cheng; Hugo R Rosen
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

4.  A different representation of natural T cells and natural killer cells between tumor-infiltrating and periphery lymphocytes in human hepatocellular carcinoma.

Authors:  Xiao-Feng Li; Dong Dai; Xiu-Yu Song; Jian-Jing Liu; Lei Zhu; Xiang Zhu; Wenchao Ma; Wengui Xu
Journal:  Oncol Lett       Date:  2017-03-06       Impact factor: 2.967

5.  Upregulation of SOCS-3 and PIAS-3 impairs IL-12-mediated interferon-gamma response in CD56 T cells in HCV-infected heroin users.

Authors:  Li Ye; Xu Wang; David S Metzger; Eric Riedel; Luis J Montaner; Wenzhe Ho
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

6.  Innate immune function in placenta and cord blood of hepatitis C--seropositive mother-infant dyads.

Authors:  Christine Waasdorp Hurtado; Lucy Golden-Mason; Megan Brocato; Mona Krull; Michael R Narkewicz; Hugo R Rosen
Journal:  PLoS One       Date:  2010-08-30       Impact factor: 3.240

7.  CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes.

Authors:  Li Ye; Xu Wang; Shihong Wang; Yanjian Wang; Li Song; Wei Hou; Lin Zhou; He Li; Wenzhe Ho
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

Review 8.  HIV and co-infections.

Authors:  Christina C Chang; Megan Crane; Jingling Zhou; Michael Mina; Jeffrey J Post; Barbara A Cameron; Andrew R Lloyd; Anthony Jaworowski; Martyn A French; Sharon R Lewin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

9.  KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.

Authors:  Jia M Wang; Yong Q Cheng; Lei Shi; Ruo S Ying; Xiao Y Wu; Guang Y Li; Jonathan P Moorman; Zhi Q Yao
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

10.  Galectin-9 functionally impairs natural killer cells in humans and mice.

Authors:  Lucy Golden-Mason; Rachel H McMahan; Michael Strong; Richard Reisdorph; Spencer Mahaffey; Brent E Palmer; Linling Cheng; Caroline Kulesza; Mitsuomi Hirashima; Toshiro Niki; Hugo R Rosen
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.